| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calmodulin binding | 7.02e-06 | 230 | 41 | 6 | GO:0005516 | |
| GeneOntologyMolecularFunction | actin filament binding | 9.75e-05 | 227 | 41 | 5 | GO:0051015 | |
| GeneOntologyMolecularFunction | U1 snRNA binding | 1.14e-04 | 8 | 41 | 2 | GO:0030619 | |
| GeneOntologyMolecularFunction | U4 snRNA binding | 1.47e-04 | 9 | 41 | 2 | GO:0030621 | |
| GeneOntologyMolecularFunction | snRNA binding | 2.18e-04 | 57 | 41 | 3 | GO:0017069 | |
| GeneOntologyMolecularFunction | actin binding | 4.07e-04 | 479 | 41 | 6 | GO:0003779 | |
| GeneOntologyBiologicalProcess | transcription by RNA polymerase I | 1.64e-05 | 79 | 40 | 4 | GO:0006360 | |
| GeneOntologyBiologicalProcess | barbed-end actin filament capping | 2.38e-05 | 29 | 40 | 3 | GO:0051016 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase I | 5.02e-05 | 37 | 40 | 3 | GO:0045943 | |
| GeneOntologyBiologicalProcess | regulation of protein depolymerization | 5.03e-05 | 105 | 40 | 4 | GO:1901879 | |
| GeneOntologyBiologicalProcess | activation of store-operated calcium channel activity | 7.65e-05 | 7 | 40 | 2 | GO:0032237 | |
| GeneOntologyBiologicalProcess | actin filament capping | 9.68e-05 | 46 | 40 | 3 | GO:0051693 | |
| GeneOntologyBiologicalProcess | positive regulation of store-operated calcium channel activity | 1.02e-04 | 8 | 40 | 2 | GO:1901341 | |
| GeneOntologyBiologicalProcess | regulation of transcription by RNA polymerase I | 1.24e-04 | 50 | 40 | 3 | GO:0006356 | |
| GeneOntologyBiologicalProcess | regulation of store-operated calcium channel activity | 1.31e-04 | 9 | 40 | 2 | GO:1901339 | |
| GeneOntologyBiologicalProcess | negative regulation of actin filament depolymerization | 1.40e-04 | 52 | 40 | 3 | GO:0030835 | |
| GeneOntologyBiologicalProcess | spliceosomal snRNP assembly | 1.56e-04 | 54 | 40 | 3 | GO:0000387 | |
| GeneOntologyBiologicalProcess | protein depolymerization | 1.71e-04 | 144 | 40 | 4 | GO:0051261 | |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex disassembly | 1.71e-04 | 144 | 40 | 4 | GO:0043244 | |
| GeneOntologyBiologicalProcess | regulation of actin filament depolymerization | 2.25e-04 | 61 | 40 | 3 | GO:0030834 | |
| GeneOntologyBiologicalProcess | protein-containing complex disassembly | 2.37e-04 | 291 | 40 | 5 | GO:0032984 | |
| GeneOntologyBiologicalProcess | peptidyl-methionine modification | 2.82e-04 | 13 | 40 | 2 | GO:0018206 | |
| GeneOntologyBiologicalProcess | actin filament depolymerization | 2.84e-04 | 66 | 40 | 3 | GO:0030042 | |
| GeneOntologyBiologicalProcess | negative regulation of actin filament polymerization | 4.14e-04 | 75 | 40 | 3 | GO:0030837 | |
| GeneOntologyBiologicalProcess | ribonucleoprotein complex biogenesis | 4.39e-04 | 515 | 40 | 6 | GO:0022613 | |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | 6.12e-04 | 358 | 40 | 5 | GO:0000398 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 6.12e-04 | 358 | 40 | 5 | GO:0000377 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | 6.43e-04 | 362 | 40 | 5 | GO:0000375 | |
| GeneOntologyBiologicalProcess | cellular response to calcium ion | 6.61e-04 | 88 | 40 | 3 | GO:0071277 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase III | 6.82e-04 | 20 | 40 | 2 | GO:0045945 | |
| GeneOntologyBiologicalProcess | negative regulation of protein depolymerization | 6.84e-04 | 89 | 40 | 3 | GO:1901880 | |
| GeneOntologyBiologicalProcess | negative regulation of protein polymerization | 7.29e-04 | 91 | 40 | 3 | GO:0032272 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transport into cytosol | 7.52e-04 | 21 | 40 | 2 | GO:0010524 | |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex disassembly | 9.59e-04 | 100 | 40 | 3 | GO:0043242 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transport | 1.23e-03 | 109 | 40 | 3 | GO:1904427 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transport into cytosol | 1.25e-03 | 27 | 40 | 2 | GO:0010522 | |
| GeneOntologyBiologicalProcess | N-terminal protein amino acid modification | 1.44e-03 | 29 | 40 | 2 | GO:0031365 | |
| GeneOntologyCellularComponent | F-actin capping protein complex | 1.27e-04 | 9 | 40 | 2 | GO:0008290 | |
| Domain | - | 3.10e-08 | 4 | 38 | 3 | 3.40.225.10 | |
| Domain | Aldolase_II/adducin_N | 3.10e-08 | 4 | 38 | 3 | IPR001303 | |
| Domain | Aldolase_II | 3.10e-08 | 4 | 38 | 3 | PF00596 | |
| Domain | Aldolase_II | 3.10e-08 | 4 | 38 | 3 | SM01007 | |
| Domain | MARCKS_1 | 4.03e-06 | 2 | 38 | 2 | PS00826 | |
| Domain | MARCKS_2 | 4.03e-06 | 2 | 38 | 2 | PS00827 | |
| Domain | MARCKS | 4.03e-06 | 2 | 38 | 2 | IPR002101 | |
| Domain | MARCKS | 4.03e-06 | 2 | 38 | 2 | PF02063 | |
| Domain | Kazal_2 | 5.30e-05 | 36 | 38 | 3 | PF07648 | |
| Domain | KAZAL | 1.11e-04 | 46 | 38 | 3 | SM00280 | |
| Domain | SPARC_Ca_bdg | 1.12e-04 | 8 | 38 | 2 | PF10591 | |
| Domain | SPARC/Testican_Ca-bd-dom | 1.12e-04 | 8 | 38 | 2 | IPR019577 | |
| Domain | KAZAL_2 | 1.43e-04 | 50 | 38 | 3 | PS51465 | |
| Domain | Kazal_dom | 1.51e-04 | 51 | 38 | 3 | IPR002350 | |
| Domain | Thyroglobulin_1 | 5.38e-04 | 17 | 38 | 2 | PF00086 | |
| Domain | TY | 5.38e-04 | 17 | 38 | 2 | SM00211 | |
| Domain | - | 5.38e-04 | 17 | 38 | 2 | 4.10.800.10 | |
| Domain | THYROGLOBULIN_1_1 | 5.38e-04 | 17 | 38 | 2 | PS00484 | |
| Domain | THYROGLOBULIN_1_2 | 5.38e-04 | 17 | 38 | 2 | PS51162 | |
| Domain | Thyroglobulin_1 | 5.38e-04 | 17 | 38 | 2 | IPR000716 | |
| Domain | Kazal_1 | 9.08e-04 | 22 | 38 | 2 | PF00050 | |
| Domain | Myb_DNA-binding | 2.30e-03 | 35 | 38 | 2 | PF00249 | |
| Domain | MYB_LIKE | 2.71e-03 | 38 | 38 | 2 | PS50090 | |
| Domain | SANT | 4.64e-03 | 50 | 38 | 2 | SM00717 | |
| Domain | SANT/Myb | 5.01e-03 | 52 | 38 | 2 | IPR001005 | |
| Domain | EF_HAND_1 | 8.18e-03 | 204 | 38 | 3 | PS00018 | |
| Domain | EF_HAND_2 | 1.15e-02 | 231 | 38 | 3 | PS50222 | |
| Domain | G-protein_beta_WD-40_rep | 1.29e-02 | 85 | 38 | 2 | IPR020472 | |
| Pathway | REACTOME_MISCELLANEOUS_TRANSPORT_AND_BINDING_EVENTS | 1.25e-05 | 25 | 26 | 3 | MM15172 | |
| Pathway | REACTOME_MISCELLANEOUS_TRANSPORT_AND_BINDING_EVENTS | 1.41e-05 | 26 | 26 | 3 | M27424 | |
| Pubmed | PWP1 SART3 IBTK MYBBP1A MARCKSL1 NKTR NKAP SMOC1 COIL TTF1 PRPF40A METAP2 NKAPD1 MARCKS ADD1 ADD3 ASPH BMS1 | 6.82e-15 | 1371 | 42 | 18 | 36244648 | |
| Pubmed | ANKRD11 SART3 NAA35 MYBBP1A MARCKSL1 STIM2 AKAP5 RPS27A DDX24 SUCO PRPF40A MARCKS ADD1 ADD2 ADD3 ASPH BMS1 | 4.50e-13 | 1487 | 42 | 17 | 33957083 | |
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | PWP1 MYBBP1A MARCKSL1 NKTR COIL DDX24 SUCO PRPF40A MARCKS BMS1 | 5.80e-12 | 330 | 42 | 10 | 33301849 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | PWP1 GEMIN5 MYBBP1A NKTR RPS27A NKAP COIL DDX24 TTF1 PRPF40A METAP2 NKAPD1 ADD1 ADD2 BMS1 | 1.66e-11 | 1318 | 42 | 15 | 30463901 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | PWP1 GEMIN5 MYBBP1A RERE NKAP REST PHF8 COIL DDX24 PRPF40A ADD1 ASPH | 8.14e-11 | 774 | 42 | 12 | 15302935 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | PWP1 SART3 MYBBP1A RPS27A COIL DDX24 METAP2 MARCKS KIAA1217 ADD1 ADD3 ASPH BMS1 | 1.62e-09 | 1257 | 42 | 13 | 36526897 |
| Pubmed | 1.64e-09 | 3 | 42 | 3 | 15834281 | ||
| Pubmed | 1.64e-09 | 3 | 42 | 3 | 18667944 | ||
| Pubmed | Targeted disruption of the beta adducin gene (Add2) causes red blood cell spherocytosis in mice. | 1.64e-09 | 3 | 42 | 3 | 10485892 | |
| Pubmed | Immunofluorescence localization of an adducin-like protein in the chromosomes of mouse oocytes. | 1.64e-09 | 3 | 42 | 3 | 1864459 | |
| Pubmed | Arterial properties in relation to genetic variations in the adducin subunits in a white population. | 1.64e-09 | 3 | 42 | 3 | 18787518 | |
| Pubmed | Role of the adducin family genes in human essential hypertension. | 1.64e-09 | 3 | 42 | 3 | 15716695 | |
| Pubmed | 6.54e-09 | 4 | 42 | 3 | 19900187 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | SART3 GEMIN5 IBTK MYBBP1A RPS27A COIL PRPF40A MARCKS KIAA1217 ADD1 ADD3 | 9.88e-09 | 934 | 42 | 11 | 33916271 |
| Pubmed | 1.78e-08 | 246 | 42 | 7 | 15345747 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 1.81e-08 | 759 | 42 | 10 | 35915203 | |
| Pubmed | MYBBP1A MARCKSL1 STIM2 RPS27A COIL PCDH9 MARCKS ADD1 ADD3 BMS1 | 2.26e-08 | 777 | 42 | 10 | 35844135 | |
| Pubmed | 5.09e-08 | 167 | 42 | 6 | 35833506 | ||
| Pubmed | 7.04e-08 | 653 | 42 | 9 | 22586326 | ||
| Pubmed | 7.23e-08 | 655 | 42 | 9 | 35819319 | ||
| Pubmed | 1.37e-07 | 332 | 42 | 7 | 25693804 | ||
| Pubmed | 1.48e-07 | 713 | 42 | 9 | 29802200 | ||
| Pubmed | The mouse adducin gene family: alternative splicing and chromosomal localization. | 2.68e-07 | 11 | 42 | 3 | 10602987 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ANKRD11 MYBBP1A NKTR RPS27A REST PHF8 COIL DDX24 TTF1 PRPF40A ASPH | 2.68e-07 | 1294 | 42 | 11 | 30804502 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | IBTK MYBBP1A STIM2 RPS27A RERE NKAP COIL DDX24 SUCO KIAA1217 BMS1 | 1.12e-06 | 1496 | 42 | 11 | 32877691 |
| Pubmed | PWP1 ANKRD11 SART3 GEMIN5 MARCKSL1 NKAP TTF1 MARCKS CRACDL ASPH BMS1 | 1.13e-06 | 1497 | 42 | 11 | 31527615 | |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | 1.32e-06 | 678 | 42 | 8 | 30209976 | |
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 19924305 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 12427140 | ||
| Pubmed | Characterization of SMOC-2, a modular extracellular calcium-binding protein. | 1.42e-06 | 2 | 42 | 2 | 12741954 | |
| Pubmed | Expression of adducin genes during erythropoiesis: a novel erythroid promoter for ADD2. | 1.42e-06 | 2 | 42 | 2 | 15963851 | |
| Pubmed | MacMARCKS, a novel member of the MARCKS family of protein kinase C substrates. | 1.42e-06 | 2 | 42 | 2 | 1516135 | |
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 19246034 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 17292354 | ||
| Pubmed | Increased expression of phosphorylated adducin in tumor cells. | 1.42e-06 | 2 | 42 | 2 | 32237935 | |
| Pubmed | Primary structure and domain organization of human alpha and beta adducin. | 1.42e-06 | 2 | 42 | 2 | 1840603 | |
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 10845937 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 18475162 | ||
| Pubmed | Adducins regulate remodeling of apical junctions in human epithelial cells. | 1.42e-06 | 2 | 42 | 2 | 20810786 | |
| Pubmed | MARCKS deficiency in mice leads to abnormal brain development and perinatal death. | 1.42e-06 | 2 | 42 | 2 | 7862670 | |
| Pubmed | MARCKS cooperates with NKAP to activate NF-kB signaling in smoke-related lung cancer. | 1.42e-06 | 2 | 42 | 2 | 33754052 | |
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 17301826 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 19425068 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 19838659 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 32908163 | ||
| Pubmed | 1.57e-06 | 163 | 42 | 5 | 16512683 | ||
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 1.76e-06 | 486 | 42 | 7 | 30940648 | |
| Pubmed | 1.84e-06 | 20 | 42 | 3 | 18723693 | ||
| Pubmed | 2.30e-06 | 731 | 42 | 8 | 29298432 | ||
| Pubmed | 3.05e-06 | 1327 | 42 | 10 | 32694731 | ||
| Pubmed | 3.84e-06 | 547 | 42 | 7 | 37267103 | ||
| Pubmed | 3.93e-06 | 549 | 42 | 7 | 38280479 | ||
| Pubmed | Assignment of the human beta-adducin gene (ADD2) to 2p13-p14 by in situ hybridization. | 4.27e-06 | 3 | 42 | 2 | 7490111 | |
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 3693401 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 29032200 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 4.67e-06 | 1082 | 42 | 9 | 38697112 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | 4.97e-06 | 569 | 42 | 7 | 30639242 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | 5.88e-06 | 377 | 42 | 6 | 38117590 | |
| Pubmed | SART3 GEMIN5 MYBBP1A PRPF40A METAP2 CRACDL KIAA1217 ADD1 ADD2 ADD3 | 5.95e-06 | 1431 | 42 | 10 | 37142655 | |
| Pubmed | 6.79e-06 | 847 | 42 | 8 | 35850772 | ||
| Pubmed | 7.27e-06 | 223 | 42 | 5 | 33731348 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | SART3 GEMIN5 MYBBP1A MARCKSL1 RPS27A PRPF40A MARCKS ADD1 ADD2 | 7.58e-06 | 1149 | 42 | 9 | 35446349 |
| Pubmed | Adducin: a physical model with implications for function in assembly of spectrin-actin complexes. | 8.53e-06 | 4 | 42 | 2 | 7642559 | |
| Pubmed | 8.53e-06 | 4 | 42 | 2 | 8626479 | ||
| Pubmed | Polymorphisms in four candidate genes in young patients with essential hypertension. | 8.53e-06 | 4 | 42 | 2 | 16497648 | |
| Pubmed | 8.53e-06 | 4 | 42 | 2 | 8810272 | ||
| Pubmed | 8.53e-06 | 4 | 42 | 2 | 22147703 | ||
| Pubmed | 1.10e-05 | 421 | 42 | 6 | 36976175 | ||
| Pubmed | 1.42e-05 | 5 | 42 | 2 | 24413172 | ||
| Pubmed | SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response. | 1.50e-05 | 259 | 42 | 5 | 30404004 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 1.61e-05 | 954 | 42 | 8 | 36373674 | |
| Pubmed | 1.70e-05 | 127 | 42 | 4 | 30442766 | ||
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | 1.92e-05 | 701 | 42 | 7 | 30196744 | |
| Pubmed | 1.96e-05 | 274 | 42 | 5 | 34244482 | ||
| Pubmed | 1.98e-05 | 467 | 42 | 6 | 30194290 | ||
| Pubmed | 2.10e-05 | 711 | 42 | 7 | 33022573 | ||
| Pubmed | 2.13e-05 | 6 | 42 | 2 | 1618855 | ||
| Pubmed | 2.39e-05 | 483 | 42 | 6 | 36912080 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 2.78e-05 | 1353 | 42 | 9 | 29467282 | |
| Pubmed | 2.98e-05 | 7 | 42 | 2 | 9679146 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | 3.94e-05 | 1415 | 42 | 9 | 28515276 | |
| Pubmed | 3.97e-05 | 8 | 42 | 2 | 8922669 | ||
| Pubmed | Region-specific saturation germline mutagenesis in mice using the Sleeping Beauty transposon system. | 3.97e-05 | 8 | 42 | 2 | 16179923 | |
| Pubmed | SMOC1 is a tenascin-C interacting protein over-expressed in brain tumors. | 3.97e-05 | 8 | 42 | 2 | 21349332 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 4.16e-05 | 1425 | 42 | 9 | 30948266 | |
| Pubmed | 4.21e-05 | 160 | 42 | 4 | 31678930 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 4.69e-05 | 807 | 42 | 7 | 22681889 | |
| Pubmed | Smoc1 and Smoc2 regulate bone formation as downstream molecules of Runx2. | 5.10e-05 | 9 | 42 | 2 | 34667264 | |
| Pubmed | 5.48e-05 | 340 | 42 | 5 | 29478914 | ||
| Pubmed | 5.66e-05 | 1139 | 42 | 8 | 36417873 | ||
| Pubmed | 6.17e-05 | 1153 | 42 | 8 | 29845934 | ||
| Pubmed | 6.18e-05 | 63 | 42 | 3 | 34718347 | ||
| Pubmed | 6.37e-05 | 10 | 42 | 2 | 19842175 | ||
| Pubmed | 6.37e-05 | 10 | 42 | 2 | 8406449 | ||
| Pubmed | 6.37e-05 | 10 | 42 | 2 | 9184108 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 8.33e-05 | 605 | 42 | 6 | 28977666 | |
| Pubmed | 9.11e-05 | 615 | 42 | 6 | 31048545 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | 9.96e-05 | 910 | 42 | 7 | 36736316 | |
| Pubmed | 1.16e-04 | 399 | 42 | 5 | 37536630 | ||
| Pubmed | 1.16e-04 | 208 | 42 | 4 | 11790298 | ||
| Interaction | RPL15 interactions | PWP1 MYBBP1A NKTR RPS27A REST COIL DDX24 TTF1 METAP2 MARCKS BMS1 | 5.81e-09 | 530 | 41 | 11 | int:RPL15 |
| Interaction | RPL31 interactions | ANKRD11 NAA35 MYBBP1A RPS27A REST PHF8 COIL DDX24 TTF1 METAP2 NKAPD1 BMS1 | 6.37e-09 | 680 | 41 | 12 | int:RPL31 |
| Interaction | NOP56 interactions | PWP1 ANKRD11 IBTK MYBBP1A NKAP PHF8 COIL DDX24 TTF1 NKAPD1 BMS1 | 1.23e-08 | 570 | 41 | 11 | int:NOP56 |
| Interaction | ZBTB2 interactions | PWP1 MYBBP1A MARCKSL1 NKTR COIL DDX24 SUCO PRPF40A MARCKS BMS1 | 1.68e-08 | 450 | 41 | 10 | int:ZBTB2 |
| Interaction | DDX23 interactions | ANKRD11 MYBBP1A NKTR NKAP PHF8 COIL DDX24 PRPF40A NKAPD1 BMS1 | 3.09e-08 | 480 | 41 | 10 | int:DDX23 |
| Interaction | NR2C2 interactions | PWP1 GEMIN5 MYBBP1A NKTR RPS27A NKAP COIL DDX24 TTF1 PRPF40A METAP2 NKAPD1 ADD1 ADD2 BMS1 | 4.58e-08 | 1403 | 41 | 15 | int:NR2C2 |
| Interaction | RPL37A interactions | 7.19e-08 | 391 | 41 | 9 | int:RPL37A | |
| Interaction | RPL7A interactions | PWP1 SART3 NAA35 MYBBP1A RPS27A REST COIL DDX24 TTF1 METAP2 BMS1 | 7.36e-08 | 679 | 41 | 11 | int:RPL7A |
| Interaction | RPS3 interactions | SART3 IBTK NAA35 MYBBP1A RPS27A REST COIL DDX24 METAP2 MARCKS BMS1 | 1.35e-07 | 721 | 41 | 11 | int:RPS3 |
| Interaction | RPL13A interactions | SART3 MYBBP1A NKTR RPS27A REST DDX24 TTF1 PRPF40A METAP2 BMS1 | 2.15e-07 | 591 | 41 | 10 | int:RPL13A |
| Interaction | RPL4 interactions | ANKRD11 SART3 GEMIN5 MYBBP1A RPS27A REST DDX24 TTF1 PRPF40A METAP2 BMS1 | 2.41e-07 | 764 | 41 | 11 | int:RPL4 |
| Interaction | HECTD1 interactions | PWP1 ANKRD11 IBTK MYBBP1A NKAP PHF8 COIL DDX24 TTF1 PRPF40A ASPH BMS1 | 3.64e-07 | 984 | 41 | 12 | int:HECTD1 |
| Interaction | RNF113A interactions | PWP1 SART3 GEMIN5 MYBBP1A RPS27A RERE NKAP COIL DDX24 PRPF40A | 9.13e-07 | 692 | 41 | 10 | int:RNF113A |
| Interaction | RPS24 interactions | 9.16e-07 | 529 | 41 | 9 | int:RPS24 | |
| Interaction | RPL13 interactions | SART3 MYBBP1A NKTR RPS27A REST DDX24 TTF1 PRPF40A METAP2 BMS1 | 1.01e-06 | 700 | 41 | 10 | int:RPL13 |
| Interaction | RPL17 interactions | 1.72e-06 | 571 | 41 | 9 | int:RPL17 | |
| Interaction | RNPS1 interactions | 1.90e-06 | 425 | 41 | 8 | int:RNPS1 | |
| Interaction | NAA40 interactions | SART3 GEMIN5 IBTK MYBBP1A RPS27A COIL PRPF40A MARCKS KIAA1217 ADD1 ADD3 | 2.74e-06 | 978 | 41 | 11 | int:NAA40 |
| Interaction | RPL18A interactions | 2.77e-06 | 447 | 41 | 8 | int:RPL18A | |
| Interaction | TSPYL5 interactions | 3.44e-06 | 51 | 41 | 4 | int:TSPYL5 | |
| Interaction | NUP43 interactions | 3.61e-06 | 625 | 41 | 9 | int:NUP43 | |
| Interaction | CSNK2B interactions | 3.61e-06 | 625 | 41 | 9 | int:CSNK2B | |
| Interaction | DDRGK1 interactions | PWP1 GEMIN5 MYBBP1A RPS27A NKAP PHF8 COIL DDX24 PRPF40A MARCKS ASPH BMS1 | 4.48e-06 | 1249 | 41 | 12 | int:DDRGK1 |
| Interaction | RNF151 interactions | 4.91e-06 | 123 | 41 | 5 | int:RNF151 | |
| Interaction | ADARB1 interactions | 5.36e-06 | 489 | 41 | 8 | int:ADARB1 | |
| Interaction | PURG interactions | 5.58e-06 | 223 | 41 | 6 | int:PURG | |
| Interaction | RPLP0 interactions | 5.62e-06 | 660 | 41 | 9 | int:RPLP0 | |
| Interaction | MECP2 interactions | PWP1 MYBBP1A NKTR RPS27A COIL DDX24 PRPF40A METAP2 NKAPD1 MARCKS ADD2 BMS1 | 6.10e-06 | 1287 | 41 | 12 | int:MECP2 |
| Interaction | RPS6 interactions | 7.36e-06 | 874 | 41 | 10 | int:RPS6 | |
| Interaction | ZC3H18 interactions | 7.59e-06 | 877 | 41 | 10 | int:ZC3H18 | |
| Interaction | ZCCHC10 interactions | 7.72e-06 | 236 | 41 | 6 | int:ZCCHC10 | |
| Interaction | WDR5 interactions | PWP1 SART3 MYBBP1A MARCKSL1 RPS27A RERE PHF8 METAP2 MARCKS ADD1 ASPH | 8.54e-06 | 1101 | 41 | 11 | int:WDR5 |
| Interaction | ANKRD29 interactions | 8.70e-06 | 20 | 41 | 3 | int:ANKRD29 | |
| Interaction | LARP7 interactions | PWP1 SART3 GEMIN5 MYBBP1A RPS27A PHF8 COIL DDX24 PRPF40A MARCKS BMS1 | 9.46e-06 | 1113 | 41 | 11 | int:LARP7 |
| Interaction | RPS14 interactions | 9.52e-06 | 529 | 41 | 8 | int:RPS14 | |
| Interaction | DDX21 interactions | 1.11e-05 | 718 | 41 | 9 | int:DDX21 | |
| Interaction | LYN interactions | 1.13e-05 | 720 | 41 | 9 | int:LYN | |
| Interaction | RPL3 interactions | 1.16e-05 | 722 | 41 | 9 | int:RPL3 | |
| Interaction | HRAS interactions | 1.20e-05 | 725 | 41 | 9 | int:HRAS | |
| Interaction | ZNF48 interactions | 1.25e-05 | 149 | 41 | 5 | int:ZNF48 | |
| Interaction | FGFBP1 interactions | 1.25e-05 | 257 | 41 | 6 | int:FGFBP1 | |
| Interaction | SIRT7 interactions | 1.47e-05 | 744 | 41 | 9 | int:SIRT7 | |
| Interaction | NKAPD1 interactions | 1.82e-05 | 161 | 41 | 5 | int:NKAPD1 | |
| Interaction | NIFK interactions | 2.34e-05 | 431 | 41 | 7 | int:NIFK | |
| Interaction | DNAJC5B interactions | 2.41e-05 | 83 | 41 | 4 | int:DNAJC5B | |
| Interaction | RPL5 interactions | 2.54e-05 | 606 | 41 | 8 | int:RPL5 | |
| Interaction | MLLT3 interactions | 2.65e-05 | 85 | 41 | 4 | int:MLLT3 | |
| Interaction | SNRPC interactions | 2.67e-05 | 440 | 41 | 7 | int:SNRPC | |
| Interaction | DNAJC9 interactions | 2.78e-05 | 296 | 41 | 6 | int:DNAJC9 | |
| Interaction | DOT1L interactions | 2.80e-05 | 807 | 41 | 9 | int:DOT1L | |
| Interaction | RPL23AP32 interactions | 2.90e-05 | 87 | 41 | 4 | int:RPL23AP32 | |
| Interaction | SNRPA1 interactions | 3.00e-05 | 300 | 41 | 6 | int:SNRPA1 | |
| Interaction | C1orf35 interactions | 3.23e-05 | 304 | 41 | 6 | int:C1orf35 | |
| Interaction | BRD7 interactions | 3.62e-05 | 637 | 41 | 8 | int:BRD7 | |
| Interaction | RPL6 interactions | 3.62e-05 | 637 | 41 | 8 | int:RPL6 | |
| Interaction | RPS19 interactions | 3.70e-05 | 639 | 41 | 8 | int:RPS19 | |
| Interaction | KLF9 interactions | 3.78e-05 | 93 | 41 | 4 | int:KLF9 | |
| Interaction | ADD2 interactions | 3.78e-05 | 93 | 41 | 4 | int:ADD2 | |
| Interaction | SRPK3 interactions | 4.02e-05 | 190 | 41 | 5 | int:SRPK3 | |
| Interaction | RPL30 interactions | 4.28e-05 | 474 | 41 | 7 | int:RPL30 | |
| Interaction | H1-4 interactions | 4.46e-05 | 656 | 41 | 8 | int:H1-4 | |
| Interaction | RPS2 interactions | 4.51e-05 | 657 | 41 | 8 | int:RPS2 | |
| Interaction | RSL1D1 interactions | 4.58e-05 | 479 | 41 | 7 | int:RSL1D1 | |
| Interaction | STX7 interactions | 4.61e-05 | 659 | 41 | 8 | int:STX7 | |
| Interaction | ZC3H10 interactions | 5.13e-05 | 200 | 41 | 5 | int:ZC3H10 | |
| Interaction | POLR1G interactions | 5.22e-05 | 489 | 41 | 7 | int:POLR1G | |
| Interaction | RPL10A interactions | 5.29e-05 | 490 | 41 | 7 | int:RPL10A | |
| Interaction | RPL28 interactions | 5.56e-05 | 494 | 41 | 7 | int:RPL28 | |
| Interaction | RC3H1 interactions | 5.57e-05 | 677 | 41 | 8 | int:RC3H1 | |
| Interaction | FAM78A interactions | 6.03e-05 | 6 | 41 | 2 | int:FAM78A | |
| Interaction | CDK9 interactions | 6.05e-05 | 685 | 41 | 8 | int:CDK9 | |
| Interaction | SRSF6 interactions | 6.23e-05 | 503 | 41 | 7 | int:SRSF6 | |
| Interaction | MACROH2A2 interactions | 6.62e-05 | 211 | 41 | 5 | int:MACROH2A2 | |
| Interaction | MYCN interactions | PWP1 SART3 MYBBP1A RPS27A NKAP COIL DDX24 PRPF40A NKAPD1 MARCKS BMS1 | 6.64e-05 | 1373 | 41 | 11 | int:MYCN |
| Interaction | FGF8 interactions | 6.78e-05 | 108 | 41 | 4 | int:FGF8 | |
| Interaction | MAGEB2 interactions | 6.97e-05 | 349 | 41 | 6 | int:MAGEB2 | |
| Interaction | POLR1E interactions | 7.08e-05 | 350 | 41 | 6 | int:POLR1E | |
| Interaction | RPS9 interactions | 7.23e-05 | 515 | 41 | 7 | int:RPS9 | |
| Interaction | SNRPB interactions | 7.41e-05 | 517 | 41 | 7 | int:SNRPB | |
| Interaction | ARL15 interactions | 8.09e-05 | 113 | 41 | 4 | int:ARL15 | |
| Interaction | IFI16 interactions | 8.09e-05 | 714 | 41 | 8 | int:IFI16 | |
| Interaction | SRPK2 interactions | 8.33e-05 | 717 | 41 | 8 | int:SRPK2 | |
| Interaction | OASL interactions | 8.59e-05 | 223 | 41 | 5 | int:OASL | |
| Interaction | AFF4 interactions | 8.66e-05 | 115 | 41 | 4 | int:AFF4 | |
| Interaction | SYNCRIP interactions | 8.66e-05 | 721 | 41 | 8 | int:SYNCRIP | |
| Interaction | RPS16 interactions | 8.91e-05 | 724 | 41 | 8 | int:RPS16 | |
| Interaction | ZC3H3 interactions | 9.15e-05 | 226 | 41 | 5 | int:ZC3H3 | |
| Interaction | RPL8 interactions | 9.61e-05 | 539 | 41 | 7 | int:RPL8 | |
| Interaction | ARL14 interactions | 9.89e-05 | 119 | 41 | 4 | int:ARL14 | |
| Interaction | LYAR interactions | 1.00e-04 | 373 | 41 | 6 | int:LYAR | |
| Interaction | CSNK2A1 interactions | 1.04e-04 | 956 | 41 | 9 | int:CSNK2A1 | |
| Interaction | COIL interactions | 1.12e-04 | 552 | 41 | 7 | int:COIL | |
| Interaction | RPL35 interactions | 1.19e-04 | 558 | 41 | 7 | int:RPL35 | |
| Interaction | PPIG interactions | 1.27e-04 | 127 | 41 | 4 | int:PPIG | |
| Interaction | SNRNP70 interactions | 1.30e-04 | 984 | 41 | 9 | int:SNRNP70 | |
| Interaction | RPS10 interactions | 1.32e-04 | 567 | 41 | 7 | int:RPS10 | |
| Interaction | PRR11 interactions | 1.39e-04 | 130 | 41 | 4 | int:PRR11 | |
| Interaction | SMOC2 interactions | 1.44e-04 | 9 | 41 | 2 | int:SMOC2 | |
| Interaction | NKAP interactions | 1.48e-04 | 132 | 41 | 4 | int:NKAP | |
| Interaction | FBXL6 interactions | 1.56e-04 | 583 | 41 | 7 | int:FBXL6 | |
| GeneFamily | SPARC family | 3.94e-05 | 8 | 22 | 2 | 1278 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.88e-03 | 53 | 22 | 2 | 532 | |
| Coexpression | STEINER_ERYTHROCYTE_MEMBRANE_GENES | 1.18e-06 | 14 | 40 | 3 | M2442 | |
| Coexpression | GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_UP | 5.92e-06 | 170 | 40 | 5 | M5657 | |
| Coexpression | WANG_CLIM2_TARGETS_DN | 8.25e-06 | 182 | 40 | 5 | M8577 | |
| Coexpression | GSE29618_BCELL_VS_MONOCYTE_UP | 1.15e-05 | 195 | 40 | 5 | M4936 | |
| Coexpression | BENPORATH_NANOG_TARGETS | 1.41e-05 | 988 | 40 | 9 | M6616 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN | 1.60e-05 | 542 | 40 | 7 | M19529 | |
| Coexpression | GSE21033_1H_VS_12H_POLYIC_STIM_DC_DN | 6.31e-05 | 141 | 40 | 4 | M7720 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | 7.14e-05 | 1215 | 40 | 9 | M41122 | |
| Coexpression | BUSSLINGER_DUODENAL_STEM_CELLS | 1.07e-04 | 311 | 40 | 5 | M40024 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | 1.96e-04 | 807 | 40 | 7 | M16651 | |
| Coexpression | GSE29618_BCELL_VS_MDC_UP | 2.16e-04 | 194 | 40 | 4 | M4943 | |
| Coexpression | GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_DN | 2.29e-04 | 197 | 40 | 4 | M3193 | |
| Coexpression | GSE20366_CD103_KLRG1_DP_VS_DN_TREG_UP | 2.38e-04 | 199 | 40 | 4 | M4341 | |
| Coexpression | GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_DN | 2.42e-04 | 200 | 40 | 4 | M9653 | |
| Coexpression | GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_UNTREATED_DN | 2.42e-04 | 200 | 40 | 4 | M7829 | |
| Coexpression | GSE40068_CXCR5POS_BCL6POS_TFH_VS_CXCR5NEG_BCL6NEG_CD4_TCELL_UP | 2.42e-04 | 200 | 40 | 4 | M9258 | |
| Coexpression | GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP | 2.42e-04 | 200 | 40 | 4 | M7525 | |
| Coexpression | GSE7852_LN_VS_FAT_TCONV_UP | 2.42e-04 | 200 | 40 | 4 | M5747 | |
| Coexpression | GSE20198_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_UP | 2.42e-04 | 200 | 40 | 4 | M7365 | |
| Coexpression | LEE_METASTASIS_AND_RNA_PROCESSING_UP | 2.69e-04 | 16 | 40 | 2 | M8887 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | ANKRD11 GEMIN5 NAA35 NKTR REST SMOC2 PCDH9 KIAA1217 ADD1 ADD3 ASPH | 3.02e-07 | 801 | 42 | 11 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 1.34e-05 | 406 | 42 | 7 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | 1.93e-05 | 790 | 42 | 9 | gudmap_developingGonad_e16.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | 2.26e-05 | 806 | 42 | 9 | gudmap_developingGonad_e12.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | 1.22e-04 | 778 | 42 | 8 | gudmap_developingGonad_e18.5_ovary_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | 1.40e-04 | 793 | 42 | 8 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 1.51e-04 | 413 | 42 | 6 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.53e-04 | 259 | 42 | 5 | gudmap_developingGonad_e12.5_epididymis_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | 1.53e-04 | 804 | 42 | 8 | gudmap_developingGonad_e12.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.71e-04 | 141 | 42 | 4 | gudmap_developingGonad_P2_ovary_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.34e-04 | 284 | 42 | 5 | gudmap_developingGonad_e16.5_epididymis_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500 | 2.92e-04 | 162 | 42 | 4 | gudmap_developingGonad_e16.5_epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_500 | 3.91e-04 | 175 | 42 | 4 | gudmap_developingGonad_e14.5_ epididymis_500_k4 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.72e-04 | 184 | 42 | 4 | gudmap_developingGonad_e14.5_ epididymis_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.41e-04 | 524 | 42 | 6 | gudmap_developingGonad_e12.5_testes_k1_1000 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.29e-08 | 200 | 42 | 6 | fc28f71ca1cd0fdae66009ae5afe175d22f2bd8c | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 3.29e-08 | 200 | 42 | 6 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.55e-07 | 190 | 42 | 5 | 52c59001a079c76249abbaa3141e9e661b83d9a0 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-IPC_like|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.03e-06 | 193 | 42 | 5 | f24bae40f5cbcfece04fbefe4e3de1b88ac90de4 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-Tnaive/CM_CD4|GI_small-bowel / Manually curated celltypes from each tissue | 1.03e-06 | 193 | 42 | 5 | 772e0370bda4bffed7798b8714e32c9e2a1d9b67 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-IPC_like-IPCs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.03e-06 | 193 | 42 | 5 | 2088f1d210c73f74685492c63065c62ac3f553e9 | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.08e-06 | 195 | 42 | 5 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.17e-06 | 198 | 42 | 5 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.17e-06 | 198 | 42 | 5 | 22e766df1276c5b14aa0d83f434f47140ebb98ea | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 1.20e-06 | 199 | 42 | 5 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-06 | 200 | 42 | 5 | f0c338877e39226a90c4effe12f6501d33542a73 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.23e-06 | 200 | 42 | 5 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-basal_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.88e-05 | 168 | 42 | 4 | 6521bead9789d626b86cbd08692c621c5a5aef33 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-basal_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.92e-05 | 169 | 42 | 4 | c3ee781735a9288ce1822b230d39bb91c1415589 | |
| ToppCell | ILEUM-non-inflamed-(3)_mature_DC|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.97e-05 | 170 | 42 | 4 | 60151394460e6f27a42fab434e8b7b2adc78b128 | |
| ToppCell | (07)_Ionocytes-(2)_GFP_FOXI1|(07)_Ionocytes / shred by cell type by condition | 2.06e-05 | 172 | 42 | 4 | 5776b638b845d054f6e884e7df0412477f48517d | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.31e-05 | 177 | 42 | 4 | aa56129d2d5a73a10e33b7162233a4d9337ee535 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs-Migratory_DCs_L.1.2.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.31e-05 | 177 | 42 | 4 | d78a6003ce2d15d7771ae385de252eec7e3c3eea | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Activated_DCs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.31e-05 | 177 | 42 | 4 | 370aee11a6dc2c6f4366a13c3171f37bc5b32d65 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.31e-05 | 177 | 42 | 4 | 70ca5b6fde2e38af1eb88a7d6e8746edba298191 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L2-4_RORB_GRIK1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.36e-05 | 178 | 42 | 4 | 674ee5095b98929c29e4f6bd56029a336cc4a38c | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Dendritic-migDC|lymph-node_spleen / Manually curated celltypes from each tissue | 2.52e-05 | 181 | 42 | 4 | 94680f8dbdf22d83801abc0819417751d363fb12 | |
| ToppCell | cellseq-Immune-Immune_Myeloid-Myeloid_Dendritic-maDC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.63e-05 | 183 | 42 | 4 | e01dacb08a9c36cf09c0b6764ce032a7232d4cdc | |
| ToppCell | (7)_DC_activated|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.68e-05 | 184 | 42 | 4 | b89871a3e36fde6daa68daf116f8c8d587554c0f | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid-Lymphoid_DC|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.74e-05 | 185 | 42 | 4 | 48de4d9fad55077732bf64eca4919103ecbc1512 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_activated|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.86e-05 | 187 | 42 | 4 | 60c2576f31a60f819deb9ec500d1f714b469df4e | |
| ToppCell | (3)_DC_activated|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.98e-05 | 189 | 42 | 4 | e977838793fc0eb1499e81018e33e4ccb4a5f0c5 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-Activated_DCs|normal_Lymph_Node / Location, Cell class and cell subclass | 3.04e-05 | 190 | 42 | 4 | 15978ddd37b521343f88b62dad1643077fc22b2b | |
| ToppCell | (3)_MNP-(3)_DC_activated|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.10e-05 | 191 | 42 | 4 | 0353bf797c4ef237b9bb82460c173c7d03cb8883 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.17e-05 | 192 | 42 | 4 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-Lgr5+_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.17e-05 | 192 | 42 | 4 | 5155f746ad57122ef735da776c96721005b8dadc | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_activated|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 3.17e-05 | 192 | 42 | 4 | e44e37e5aeba8628556020d05e1606b28e2faa4f | |
| ToppCell | COVID-19-lung-Lymphatic_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.17e-05 | 192 | 42 | 4 | cbe57cda44232b183821ac633b60a2668265e616 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-05 | 193 | 42 | 4 | d8ccfb780a75bdf9141f41fb29a076958601ebb4 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass | 3.23e-05 | 193 | 42 | 4 | 024d30eb143d8278c0851c3a6c9426226fa3b480 | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-SST-MGE1-4|World / Primary Cells by Cluster | 3.23e-05 | 193 | 42 | 4 | 2eb6e4cff4fe3ce564c1581f6f7df4834895aaa9 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-05 | 194 | 42 | 4 | ba529c051f248d29f4222f4bc9801ba233859093 | |
| ToppCell | severe_COVID-19-CD4+_T_naive|severe_COVID-19 / disease group, cell group and cell class (v2) | 3.30e-05 | 194 | 42 | 4 | 4b86f3cc173ea779399d5b3598b45b25f60a4395 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-IPC_like|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.30e-05 | 194 | 42 | 4 | 3e90be6f5b1c5c83632e62941fb18d6a627ec1b5 | |
| ToppCell | tumor_Lung-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass | 3.37e-05 | 195 | 42 | 4 | 72a7c4beb880390b29f3c5d6dd9dbb082af50fe2 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_activated|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.37e-05 | 195 | 42 | 4 | ecf7d9856a5b507ec17c325c9a772dc5a184bc8e | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-IPC_like-IPCs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.37e-05 | 195 | 42 | 4 | da8680a91648843901e456b5faef5e85039ade15 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-IPC_like-IPCs/Immature_PNs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.37e-05 | 195 | 42 | 4 | 5e36a881fe2646f5a95d07d7b9265e6ada38730c | |
| ToppCell | 10x3'2.3-week_17-19|World / cell types per 3 fetal stages;per 3',per 5' | 3.50e-05 | 197 | 42 | 4 | f5cfad0b42d0f817e22cc78b9bfb2b4b7e4330ed | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Dendritic-dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.50e-05 | 197 | 42 | 4 | 2a140c61e81aa18de2c9c1c443e314d6f09cdc18 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.50e-05 | 197 | 42 | 4 | fa3fe934bd5fd8c6520a9c46357f9e441c794aba | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Naive_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.50e-05 | 197 | 42 | 4 | 836dd8110d5689f944ad1d301def38c32278b5b5 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs-Migratory_DCs_L.1.2.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.50e-05 | 197 | 42 | 4 | 32eb4437cc608b8369e376446d639497ecfdd17a | |
| ToppCell | PBMC_fresh-frozen|World / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.57e-05 | 198 | 42 | 4 | dcc223a0396b8b673e4ed8c6733ec6cd74e9a03a | |
| ToppCell | Enterocyte_Progenitors|World / shred on cell type and cluster | 3.64e-05 | 199 | 42 | 4 | 776bcc887927dea9ebd76ec4338ce2225c319c2c | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pre_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.64e-05 | 199 | 42 | 4 | dd94e42b62af7cbd69c472681d3c758552694ae2 | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD4+_Naive_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.64e-05 | 199 | 42 | 4 | 885bc902b6e2af0b61e452c4154160cd3f1cf98e | |
| ToppCell | Caecum-T_cell-Activated_CD4_T|T_cell / Region, Cell class and subclass | 3.64e-05 | 199 | 42 | 4 | 13173cc4dcc8e856680372b0a4ad4f36afa892c1 | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 3.64e-05 | 199 | 42 | 4 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Mesothelium|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.64e-05 | 199 | 42 | 4 | 6cfefd81e8a1a883fb4279ac4ab0b298ed2a0817 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 3.64e-05 | 199 | 42 | 4 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | BAL-Severe-cDC_10|Severe / Compartment, Disease Groups and Clusters | 3.64e-05 | 199 | 42 | 4 | 54bdadd04abaf8caa948b0177c037bc089ca07e6 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 3.64e-05 | 199 | 42 | 4 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.72e-05 | 200 | 42 | 4 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.72e-05 | 200 | 42 | 4 | 89a6da2bdedc6b1ad0675c8753bf2b763a99af6a | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal-Neuron|3m / Sample Type, Dataset, Time_group, and Cell type. | 3.72e-05 | 200 | 42 | 4 | 3d134ae3c48ff4d1849db4fbe44ff73fb6c8c779 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-OPC_related-Oligodendrocyte/OPC|3m / Sample Type, Dataset, Time_group, and Cell type. | 3.72e-05 | 200 | 42 | 4 | 7557ea33c3d080d0fa4ca0c2703279932d01e6d0 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Neuronal-Intermediate|1m / Sample Type, Dataset, Time_group, and Cell type. | 3.72e-05 | 200 | 42 | 4 | 805f50236113713b02f77aa5e208efb3b3b959d5 | |
| ToppCell | Control_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 3.72e-05 | 200 | 42 | 4 | 3372c488a39fe812fa94e4f0564594186fea3db5 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Alv_Gen_Intermediate|Control_saline / Treatment groups by lineage, cell group, cell type | 3.72e-05 | 200 | 42 | 4 | 041a34080120c9f613373c20dcc366292f558040 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-OPC_related|3m / Sample Type, Dataset, Time_group, and Cell type. | 3.72e-05 | 200 | 42 | 4 | 3dcaeb9f1e387784c299bfe0da1516598f82edf5 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-OPC_related-Oligodendrocyte/OPC|1m / Sample Type, Dataset, Time_group, and Cell type. | 3.72e-05 | 200 | 42 | 4 | 80cec67b7557465320a847ba959a8a13f7c51566 | |
| ToppCell | Control_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 3.72e-05 | 200 | 42 | 4 | e77eba6172cabf85b8028638ed35299f2f079cd8 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-OPC_related|1m / Sample Type, Dataset, Time_group, and Cell type. | 3.72e-05 | 200 | 42 | 4 | 8dafb90b418f91a0fb56c97db06233d3eca358dc | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_dendritic-plasmacytoid_dendritic_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.23e-04 | 142 | 42 | 3 | 7fa6b0f493634d25d68b4365b8c82cd43f5d31db | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-HSC/MPP_and_pro-eo/baso/mast_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.36e-04 | 144 | 42 | 3 | 4f46a22dba047d35076e7768e834b0cbcecc8417 | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.79e-04 | 150 | 42 | 3 | 70ac8ae4b1683fb17278a8e4606f2fa0b94988c0 | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-maDC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.02e-04 | 153 | 42 | 3 | b03375c54aa701817c0fc2c3fef32b870169e697 | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-maDC-maDC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.02e-04 | 153 | 42 | 3 | 18bd770a18e642581a6df144d47184c1ac383713 | |
| ToppCell | COVID-19-lung-Mesothelial|lung / Disease (COVID-19 only), tissue and cell type | 4.25e-04 | 156 | 42 | 3 | e1f563869b3bf997eaa2e756e31b53db1a478903 | |
| ToppCell | AT1-AT2_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 4.41e-04 | 158 | 42 | 3 | 3bc51cfd37b289cc3e866b54ce55a298e5eff690 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.58e-04 | 160 | 42 | 3 | 7064af50fc10e3ea03badf415306222b74db0f95 | |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.75e-04 | 162 | 42 | 3 | 86a0b9dabd150dc993bfc0f3344804de7f8e4042 | |
| ToppCell | Healthy_Control-Lymphoid-B-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 4.83e-04 | 163 | 42 | 3 | d84bd41b4494c7d5c7f88d511bfe481fb12f079d | |
| ToppCell | LPS-IL1RA-Unknown-Endothelial-Monocytes-Macrophages|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.83e-04 | 163 | 42 | 3 | 6b11a3ada8725670d0489f404c8c2175ad3904e9 | |
| ToppCell | Healthy_Control-Lymphoid-B|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 4.83e-04 | 163 | 42 | 3 | 0f723ec2503afa1b3ebb0754972438ffb6e6179d | |
| ToppCell | 5'-Adult-Appendix-Epithelial-goblet-BEST2+_Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.92e-04 | 164 | 42 | 3 | 29da0175bd3808a5b3039a6161c764105608ef96 | |
| ToppCell | 5'-Adult-Appendix-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.92e-04 | 164 | 42 | 3 | e83b632ac7e1dace946991ddfe1fbfbbffc3a88b | |
| ToppCell | 367C-Myeloid-Monocyte-CD16+_Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.92e-04 | 164 | 42 | 3 | 1aff83fc73b4e41e6f0d4b04dbca153bcc7a3518 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_activated|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.92e-04 | 164 | 42 | 3 | eae6d440877b292ad18dc4bd02802dda5b2f9c60 | |
| ToppCell | COVID-19-lung-Mesothelial|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.92e-04 | 164 | 42 | 3 | 83303e2ba52008391b8dc3fae8225ab5bcb20063 | |
| ToppCell | control-Epithelial-Ionocyte|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.01e-04 | 165 | 42 | 3 | 5cfba9a46bd8ceeca74a6493057b4d38af6b06fe | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.09e-04 | 166 | 42 | 3 | ceb0a48c0d853448fd45ac31dde046df9a178571 | |
| ToppCell | Control-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 5.09e-04 | 166 | 42 | 3 | 32ebaefa6c074b28193fff764ee7c2c0e9357e20 | |
| ToppCell | NS-control-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.09e-04 | 166 | 42 | 3 | 6d9fb239f69ba519844f593c00d515e1aac4ff50 | |
| ToppCell | Control-Epithelial-Mesothelial|Control / Disease state, Lineage and Cell class | 5.09e-04 | 166 | 42 | 3 | 1ed3788257e14f097862b999f020bfe2a57de52b | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.09e-04 | 166 | 42 | 3 | d373f1092e85eeb317a7406032b259f11e6adbe0 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.09e-04 | 166 | 42 | 3 | f453a1d545d59003d98485ac31e85e6cf451817c | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-Tnaive/CM_CD4|Liver / Manually curated celltypes from each tissue | 5.18e-04 | 167 | 42 | 3 | ab6273ae5d76a3f9a05c58320e3dee80f9b99e47 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-04 | 167 | 42 | 3 | 3dfec2fcc36caa6e394efae5e540a6fa28759977 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-04 | 167 | 42 | 3 | 95b3b5ba3414729f0460a26a0deca48de0cbe33e | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_activated|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.18e-04 | 167 | 42 | 3 | 43a9375fdbafd7450c553e4620e21537e08639dd | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-04 | 167 | 42 | 3 | 9480739587d51e67a281778b9bddd7b5ffc3ad92 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.27e-04 | 168 | 42 | 3 | b96a48552f4236a95bbcdce2f1b05041086d7101 | |
| ToppCell | control-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.27e-04 | 168 | 42 | 3 | 327b02f19f4a8607c033203824fdc60a1254331f | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 9.55e-10 | 179 | 41 | 8 | 4585_DN | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.74e-08 | 177 | 41 | 7 | 985_DN | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 2.85e-08 | 178 | 41 | 7 | 3998_DN | |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 2.14e-05 | 188 | 41 | 5 | 6735_DN | |
| Drug | rostafuroxin | 3.15e-05 | 5 | 41 | 2 | ctd:C106263 | |
| Disease | spastic quadriplegic cerebral palsy 3 (implicated_via_orthology) | 1.97e-09 | 3 | 38 | 3 | DOID:0081361 (implicated_via_orthology) | |
| Disease | cerebral palsy (implicated_via_orthology) | 2.35e-07 | 10 | 38 | 3 | DOID:1969 (implicated_via_orthology) | |
| Disease | hypertension (implicated_via_orthology) | 6.02e-04 | 128 | 38 | 3 | DOID:10763 (implicated_via_orthology) | |
| Disease | smoking status measurement | 6.18e-04 | 1160 | 38 | 7 | EFO_0006527 | |
| Disease | IgA glomerulonephritis (is_implicated_in) | 6.87e-04 | 30 | 38 | 2 | DOID:2986 (is_implicated_in) | |
| Disease | hydroxy-leucine measurement | 1.54e-03 | 45 | 38 | 2 | EFO_0005276 | |
| Disease | pain | 2.05e-03 | 196 | 38 | 3 | EFO_0003843 | |
| Disease | mean arterial pressure | 3.78e-03 | 499 | 38 | 4 | EFO_0006340 | |
| Disease | Autism Spectrum Disorders | 5.39e-03 | 85 | 38 | 2 | C1510586 | |
| Disease | visual epilepsy (biomarker_via_orthology) | 6.02e-03 | 90 | 38 | 2 | DOID:11832 (biomarker_via_orthology) | |
| Disease | daytime rest measurement | 6.44e-03 | 295 | 38 | 3 | EFO_0007828 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PASAHKNKSKKKKKK | 211 | Q15361 | |
| LLGPTHKKKSKKKKK | 266 | Q15361 | |
| LAPILRRKKKKKKLD | 301 | P48751 | |
| SKPKKKSKKHKDKER | 446 | P55199 | |
| KKKSKDRPSKLEKKN | 766 | Q6UB99 | |
| KKKFRTPSFLKKNKK | 686 | Q9UEY8 | |
| VKKKKPKLLNKFDKT | 326 | Q12797 | |
| KKNSGPKAAKKKKRL | 11 | Q14692 | |
| KKTLKNKSSKKSSKP | 581 | Q13127 | |
| KKKRRKKKKSKGPSA | 36 | P50579 | |
| KKAKTKAKKKPRKRS | 976 | Q9P2D0 | |
| KKKLRKKGKKTLDAL | 626 | Q5BJE1 | |
| NKKKKRKKRKSPKSS | 866 | Q9HC56 | |
| KTRKPKKKTRKPSKK | 281 | Q9UHL3 | |
| KRKSPKKKEKCEYKK | 181 | P38432 | |
| KKSKFKTFKKFFGKK | 26 | Q6NV74 | |
| SKKRKKKGFLPETKK | 1166 | Q9BQG0 | |
| KKGFLPETKKRKKRK | 1171 | Q9BQG0 | |
| YKKSKKHKKKSKKRR | 866 | O75400 | |
| PKKKKKFSFKKPFKL | 86 | P49006 | |
| CFKRRKKAAKALKPK | 36 | P24588 | |
| PKKKKKRFSFKKSFK | 151 | P29966 | |
| KSSSPKKKIKLKKSK | 91 | Q9GZR7 | |
| SCLSKQKKKKTKKPK | 831 | Q9GZR7 | |
| AEKKALKKKKKIRGP | 606 | Q15020 | |
| KPKKKTRKPSKKSRW | 361 | P0C7A2 | |
| KKKHRSKKYKKKRSK | 241 | Q8N5F7 | |
| SKKYKKKRSKKSRKE | 246 | Q8N5F7 | |
| LKKKKTTVKKKTLNP | 321 | Q8N9I0 | |
| KLKGKKDKKHKAPKR | 996 | P30414 | |
| KLPPRHKKKKKKKFS | 371 | Q9H2Y9 | |
| FESPKKKFKFKFPKK | 1566 | Q5T5P2 | |
| STKKNKKKPPKKKSR | 71 | Q9P2R6 | |
| KKKFRTPSFLKKSKK | 706 | P35612 | |
| SKKKKKFRTPSFLKK | 716 | P35611 | |
| KKKSRKKSLKKPALF | 206 | Q6ZUT1 | |
| VFTLGSKLSKKKKKK | 231 | Q13610 | |
| PFKRYVKKKAKPKKC | 386 | Q9H4F8 | |
| KKTKKKKKVRPLSRE | 561 | Q5VZE5 | |
| SKKPSKIKSLFKKKS | 731 | Q9P246 | |
| KRFLRKKSKPKKCVK | 376 | Q9H3U7 | |
| KKRLSQPKAKPKKKK | 731 | Q8TEQ6 | |
| SSKKIKHCKLKKKSK | 156 | A0A1B0GTY4 | |
| KFSPEKKKKRCKYKI | 1101 | Q9UBS9 | |
| SKKKGLKPKELFKKA | 526 | Q9UPP1 | |
| GAKKRKKKSYTTPKK | 76 | P62979 | |
| KKKSYTTPKKNKHKR | 81 | P62979 |